We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
AYOXXA BIOSYSTEMS Appoints Dr. Gerald Möller as Chairman of the Board
News

AYOXXA BIOSYSTEMS Appoints Dr. Gerald Möller as Chairman of the Board

AYOXXA BIOSYSTEMS Appoints Dr. Gerald Möller as Chairman of the Board
News

AYOXXA BIOSYSTEMS Appoints Dr. Gerald Möller as Chairman of the Board

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "AYOXXA BIOSYSTEMS Appoints Dr. Gerald Möller as Chairman of the Board"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AYOXXA Biosystems GmbH has announced that Dr. Gerald Möller has joined the company's supervisory board as an independent board director and chairman of the board. With 40 years of experience in Pharma, Diagnostics and Biotech, Dr. Möller will guide AYOXXA’s strategic expansion from life science research into disease specific applications, where LUNARIS™, AYOXXA’s unique and new multiplexing technology enables researchers in academia and the pharma industry to address the importance of proteomics in discovery and development of new medicines.

In the early commercialization phase AYOXXA’s customers gave very encouraging feedback and have seen how LUNARIS™ multiplex protein quantification platform is helping them to answer important questions about complex diseases and personalized medicine.

Rainer Christine comments: “It was a great pleasure for me to be an investor and the chairman of AYOXXA during the company’s early stages. With the launch of its first products, AYOXXA is now entering a new phase. I am thrilled that Dr. Gerald Möller will from now on chair AYOXXA’s board and bring to bear his vast experience and excellent reputation in the field.”

Dr. Andreas Schmidt CEO and Co-founder of AYOXXA Biosystems GmbH comments: “I am excited about his commitment as new chairmen and investor of AYOXXA. What we see in genomics will be complemented by better understanding the power of proteomics. With Gerald Möller we found an experienced international leader to take up this challenge together with the board and management of AYOXXA.

“Over the last years I have been active in the fields of genomics and tissue phenomics and supported their important and growing impact in precision medicine. I am excited about the potential of the AYOXXA multiplexing platform which could become a strong vehicle to unlock the power of proteomics in the discovery and development of new diagnostics and therapeutics, both in academia and industry. With the first products moving into the markets it is an optimal time for me to join and help. I am impressed by what the people at AYOXXA have accomplished so far”, says Dr. Gerald Möller.

Advertisement